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Abstract
Introduction: For patients with chronic pancreatitis presenting with medically intractable abdominal pain, surgical
intervention may be the only treatment option. However, extensive pancreatic resections are typically performed
open and are associated with a substantial amount of postoperative pain, wound complications and long recovery
time. Minimally invasive surgery offers an avenue to improve results; however, current limitations of laparoscopic
surgery render its application in the setting of chronic pancreatitis technically demanding. Additionally, pancreatic
resections are associated with a high incidence of diabetes. Transplantation of islets isolated from the resected
pancreas portion offers a way to prevent post-surgical diabetes; however, preservation of the vascular supply
during pancreatic resection, which determines islet cell viability, is technically difficult using current laparoscopic
approaches. With recent advances in the surgical field, robotic surgery now provides a means to overcome these
obstacles to achieve the end goals of pain relief and preserved endocrine function. We present the first report of a
novel, minimally invasive robotic approach for resection of the pancreatic head that preserves vascular supply and
enables the isolation of a high yield of viable islets for transplantation.
Case presentation: A 35-year old Caucasian woman presented with intractable chronic abdominal pain secondary
to chronic pancreatitis, with a stricture of her main pancreatic duct at the level of the ampulla of Vater and distal
dilatation. She was offered a robotic-assisted pylorus-preserving pancreatoduodenectomy and subsequent islet
transplantation, to both provide pain relief and preserve insulin-secretory reserves.
Conclusion: We present a novel, minimally invasive robotic approach for resection of the pancreatic head with
complete preservation of the vascular supply, minimal warm ischemia time (less than three minutes) and excellent
islet recovery (134,727 islet equivalent). Our patient is currently pain-free with normal glycemic control. Robot-
assisted pylorus-preserving pancreatoduodenectomy and autologous islet transplantation can be safely performed
and has the potential to minimize operative traumas as well as to partially preserve endocrine function. Results
from this case report suggest that this dual procedure should be considered as a treatment option for patients
with chronic pancreatitis at earlier stages of the disease, before irreversible islet loss occurs.
Introduction
Chronic pancreatitis (CP) is an inflammatory process of
the pancreas characterized by irreversible morphological
changes that can lead to impaired endocrine and exo-
crine function. The treatment of patients with CP
remains controversial; conservative treatment is typically
preferred over surgery. Surgical intervention is often
considered late in the course of the disease and remains
the last resort for patients presenting with medically
intractable abdominal pain [1]. In these cases, treatment
needs to be adapted to the individual situation, as CP is
a heterogeneous group of diseases with different etiolo-
gies and presentations. Several aspects must be consid-
ered, such as the surgical approach, metabolic
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decompression of the pancreatic duct may be the most
appropriate treatment if the pancreatic duct is dilated,
whereas partial or total pancreatic resection may be the
only option if the pancreatic duct is normal in size or
narrow. In patients whose symptoms are not resolved
after drainage procedures or partial pancreatic resec-
tions, or those who have diffuse involvement of the
gland, a total pancreatectomy may be the only treatment
option [2].
While total pancreatectomy classically provides pain
relief in about 70% of patients [2], it is not an innocuous
procedure. Extensive pancreatic resections are typically
performed open and are associated with a substantial
amount of postoperative pain, wound complications and
long recovery time. While this has motivated several
attempts to adopt a minimally invasive approach,
laparoscopic pancreatic surgery persists as one of the
most challenging applications of minimally invasive sur-
gery. Since the first report of laparoscopic pylorus-pre-
serving pancreatoduodenectomy in 1994, further
attempts have failed to report significant benefits over
an open approach [3,4]. A recent literature review of
146 procedures since 1994 found that a laparoscopic
approach is not universally accepted due to the technical
difficulty for the surgeon, length of operating time and
the absence of a reduced length of hospital stay for the
patient [5].
Recently, surgeons have begun to overcome the limita-
tions of traditional laparoscopic surgery through robotic
surgery. The robotic system improves the performance
of minimally invasive surgery by restoring three-dimen-
sional vision, enhancing surgeon dexterity and eliminat-
ing tremor. Recently, we published the largest series of
robotic pancreatic surgeries (n = 124) to date, demon-
strating both feasibility and safety [6]. Additional
attempts have demonstrated the success of robot-
assisted pancreatic resections and reconstructions [7].
Although the main goal of the operation is to improve
the quality of life in patients with CP by providing pain
relief, metabolic consequences should not be ignored.
Post-pancreatectomy diabetes is typically brittle, as a
result of concomitant deficiency in insulin secretion and
counter regulatory hormones, and difficult to manage.
Continued alcohol abuse or poor nutrition, combined
with maldigestion, further complicate this management.
It has been found that Whipple procedures (the standard
pancreatoduodenectomy) result in a 20% increase in the
incidence of diabetes [1]. In patients seeking surgical
treatment for CP, the cost of long-term morbidity from
diabetes and endocrine deficiency must be assessed.
Autologous islet transplantation (AIT), first reported
to preserve islet function following a near-total pancrea-
tectomy in 1977, has been consistently demonstrated as
a safe procedure that can prevent diabetes long-term in
patients with CP [8-10]. The success rate largely
depends on the amount of islets infused and their viabi-
lity, which is directly linked to the extent of ischemia
they are exposed to during the pancreatectomy [9]. In
order to avoid extended warm ischemia time, the vascu-
lar supply of the pancreas needs to be preserved until
the last moment of the resection. Preservation of the
vascular supply is difficult during a standard Whipple
procedure. Additionally, the insulin-secretory reserves of
the pancreatic remnant are typically sufficient to prevent
postsurgical diabetes. Therefore, most surgeons would
not consider isolating islets from solely the pancreatic
head. However, the fate of the pancreatic remnant is
unknown. Progressive fibrosis may destroy the remain-
ing islets over time or lead to pain recurrence, necessi-
tating a complete pancreatectomy. Furthermore, the
probability of insulin independence after AIT progres-
sively declines with increasing fibrosis [8]. Thus, it
would be beneficial to preserve islets during the initial
pancreatic head resection.
In addition to providing a platform to perform a mini-
mally invasive pancreatectomy in the technically
demanding setting of CP, robot assistance offers the
possibility to preserve the vascular supply of the pan-
creatic head during surgery for islet isolation. In consid-
eration of the high rate of diabetes (approximately 50%
five years after onset) observed in the natural history of
CP [11,12], surgical intervention that successfully pro-
vides pain relief and preserves the endocrine function
earlier in the course of CP would be of significant bene-
fit to the patient. Herein we present a case report docu-
menting our experience with robot-assisted pylorus-
preserving pancreatoduodenectomy (RA-PPPD) with
minimal warm ischemia time and excellent islet recov-
ery for AIT in a patient with CP.
Case presentation
Our patient was a 35-year old Caucasian woman with
CP of unknown etiology. Her main complaint at the
time of the consultation was severe chronic abdominal
pain refractory to narcotic pain medication. Addition-
ally, she was experiencing nausea and vomiting. Her
pancreatic function was normal, with a hemoglobin A1C
l e v e lo f5 . 4 %a n db a s a lC - p e p t i d el e v e lo f1 . 3n g / m L .
The history of her present illness was significant for sev-
eral episodes of recurrent pancreatitis over the past six
years after undergoing an open cholecystectomy with
subsequent removal of a retained common bile duct
stone by endoscopic retrograde cholangiopancreatogra-
phy (ERCP). Her past medical history was also signifi-
cant for psoriasis and heavy alcohol consumption, which
likely contributed to the subsequent development of CP,
although she reported abstinence for the past year.
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and demonstrated the presence of a previous sphincter-
otomy and a dilated common bile duct of approximately
11 mm without filling defects. A stricture of her main
pancreatic duct was observed at the level of the ampulla
of Vater; dilatation of the remaining portion of the pan-
creatic duct was present. An endoscopic ultrasound was
performed and revealed sonographic changes consistent
with mild CP (2.5 mm pancreatic duct, heterogeneous
parenchyma) according to the Cambridge classification
[13]. Magnetic resonance cholangiopancreatography and
computed tomography of her abdomen were also per-
formed and demonstrated findings consistent with those
observed in the ERCP. Given the young age of our
patient, we gave priority to surgical therapy to avoid
additional endoscopic procedures. After discussing the
various therapeutic options with our patient, she chose
an RA-PPPD, for better drainage of the distal pancreas
and pain relief. Additionally, in consideration of her
young age and the future unknown fate of the pancrea-
tic remnant, our patient was offered AIT to preserve
endocrine function.
After induction of general anesthesia, our patient was
placed in the lithotomy position, with slight reverse
Trendelenburg, and her abdomen was prepared and
draped in the usual sterile fashion. Trocars were placed
as indicated in Figure 1. The Da Vinci robotic surgical
system (Intuitive Surgical, Inc. Sunnyvale, CA, USA) was
docked into position, with a viewpoint from our
patient’s head. We mobilized the right colonic flexure,
exposed the second portion of her duodenum and com-
pleted mobilization of the pancreatic head. The pancrea-
tic head was enlarged and fibrotic. Next, her hepatic
hilum was dissected, her common hepatic artery was
exposed and her right gastric artery was ligated. The ori-
gin of her gastroduodenal artery was prepared with a
vessel loop but not divided (Figure 2A) to preserve the
blood supply to the head of the pancreas. The dissection
of her gastrocolic ligament was completed, exposing the
inferior border of her pancreas and the pancreatic neck.
The neck of her pancreas was prepared and her superior
mesenteric vein was widely exposed. Next, the pylorus
was prepared; her right gastroepiploic artery and vein
were divided. The first portion of her duodenum was
divided 2 cm distal to the pylorus using a stapling
device. The first loop of her jejunum was transected
using a stapler device as well. Her duodenum was
retracted, exposing the uncinate process. Subsequently,
her common bile duct was transected and the dissection
was conducted in the neck of her pancreas, dividing the
pancreatic neck with the Harmonic scalpel. Her pan-
creatic duct was enlarged, measuring approximately 3
mm to 4 mm. The dissection proceeded cautiously until
the entire head of her pancreas was connected only to
her gastroduodenal artery and superior pancreaticoduo-
denal vein. Immediately before the transection, a small
Pfannenstiel incision was made; a hand access device
(Lap Disc, Ethicon, Cincinnati, OH, USA) was inserted
with the aim of preserving the pneumoperitoneum. At
this point, her gastroduodenal artery and superior pan-
creaticoduodenal vein were clipped and divided (Figure
2B, C). The specimen was placed in an endobag and
extracted immediately through the mini laparotomy pre-
viously performed. Her pancreas was flushed with Uni-
versity of Wisconsin solution on the back-bench and
brought to the islet isolation facility in a sterile bag on
ice for processing.
In the interim, the reconstruction phase of the operation
was initiated. A pancreaticogastrostomy was performed.
Next, a retrocolic end-to-side hepaticojejunostomy was
created with the first loop of her jejunum. The last anasto-
mosis was an end-to-side two layer pylorojejunostomy, 40
cm distal to the hepaticojejunal anastomosis. Once the
reconstruction was completed, her inferior mesenteric
vein was dissected and canulated with a 16-gauge canula
in preparation for the islet cell infusion.
The islet isolation procedure was conducted as pre-
viously described [14]. In brief, the pancreatic duct was
canulated and injected with a purified collagenase solu-
tion (Serva, Heidelberg, Germany). The pancreas was
cut into small pieces and placed into a modified Ricordi
digestion system. Under microscopic control of repeat
samples, the digestion was stopped by dilution and
A 
A 
A 
C  B 
Figure 1 Trocar Positioning. (A) Three 7 mm trocars, for the
robotic arms, were inserted - two on her right flank and one in the
upper left quadrant. (B) One 12 mm trocar, for the robotic scope,
was inserted towards the right of her umbilicus. (C) Another 12 mm
trocar, for the assistant, was inserted toward the left side of her
umbilicus.
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exocrine tissue. The digest was collected and washed
under repeat centrifugation. After a quality assessment
the islet preparation was placed into several syringes
and brought into the operating room. The islets were
successfully infused into the portal stream and her infer-
ior mesenteric vein was subsequently ligated (Figure 3).
To conclude, two Jackson Pratt #10 drainages were
placed - one adjacent to the pancreatic anastomosis and
one underneath her liver.
Our patient tolerated the procedure well. The weight
of the resected pancreas portion was 47 g, after trim-
ming of non-pancreatic tissue. Fifteen milliliters of tis-
sue containing 134,727 islet equivalent (IEQ; 2867 IEQ
per gram of pancreas or 2449 IEQ per kilogram of the
recipient body weight) were collected. The viability of
the tissue was 97%, as measured by propidium iodide
and cytogreen fluorescent staining. The operation lasted
six hours and thirty minutes, with an estimated blood
loss of 200 mL. Our patient was maintained on an intra-
venous insulin drip during the first two days after the
operation. She was subsequently transitioned to 4U to
6U of long-acting insulin daily. Our patient’s recovery
was uneventful; her C-peptide level on the eighth post-
operative day was 2.2 ng/mL. She was discharged home
on the ninth postoperative day with pain improvement
and was maintained on low dose insulin. During her last
follow-up 45 days after the surgery, she was normogly-
cemic without any insulin injection and reported com-
plete resolution of her pain.
Discussion
In this case, we were able to preserve the vascular sup-
ply to the pancreatic head until the conclusion of the
procedure, ligating the gastroduodenal artery immedi-
ately before transecting the head of the pancreas. This
was facilitated by a view and approach, provided by the
position of the robotic arms and three-dimensional cam-
era, that is difficult and only rarely possible in open sur-
gery. The warm ischemia time was under three minutes
a n dw ew e r ea b l et oi s o l a t e2 4 4 9I E Q / k g ,w h i c hi sa
remarkable islet yield considering that only the pancrea-
tic head was resected. The chances of remaining insulin
independent are significantly increased if the islet yield
is above 2500 IEQ/kg [8-10].
Conclusion
We present a novel, minimally invasive robotic approach
for resection of the pancreatic head with complete preser-
vation of the vascular supply, minimal warm ischemia
time and excellent islet recovery. RA-PPPD and AIT can
be safely performed, with the potential to minimize opera-
tive trauma and partially preserve endocrine function.
Transplantation of a high yield of viable islets from the
resected pancreatic portion in our patient reduces the risk
of her developing diabetes in the future. Pancreatic resec-
tion for CP has good long-term efficacy for pain control,
but is typically performed late in the course of the disease.
With the availability of RA-PPPD and AIT, surgical inter-
vention should be considered and offered earlier, to pre-
serve endocrine function before irreversible islet loss.
A B C 
Figure 2 Resection of the pancreatic head. (A) The gastroduodenal artery (GDA) was prepared and a vessel loop was placed. Once the
pancreatic head was completely mobilized, the GDA was (B) ligated and (C) transected, with immediate removal of the specimen for cold flush
with preservation solution on the back-bench.
Figure 3 Ligation of her inferior mesenteric vein.H e ri n f e r i o r
mesenteric vein was identified, dissected and distally ligated. A
canula was inserted for infusion of the pancreatic digest for
autologous islet transplantation.
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Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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